Clinical Trial Update: Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating cetuximab in squamous cell carcinoma of the skin expressing EGFR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Centre Hospitalier of Chartres | Conditions: Skin Diseases, Carcinoma, Squamous Cell | Phase 2 | Status: COMPLETED